Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Parasit Vectors ; 9(1): 359, 2016 06 24.
Article in English | MEDLINE | ID: mdl-27342652

ABSTRACT

BACKGROUND: Species of the genus Borrelia are causative agents of Lyme disease and relapsing fever. Lyme disease is the most commonly reported vector-borne disease in the northern hemisphere. However, in some parts of the world Lyme borreliosis and relapsing fever may be caused by novel Borrelia genotypes. Herein, we report the presence of a Borrelia sp. in an Amblyomma varanense collected from Python reticulatus. METHODS: Ticks were collected from snakes, identified to species level and examined by PCR for the presence of Borrelia spp. flaB and 16S rRNA genes. Phylogenetic trees were constructed using the neighbour-joining method. RESULTS: Three A. varanense ticks collected from P. reticulatus were positive for a unique Borrelia sp., which was phylogenetically divergent from both Lyme disease- and relapsing fever-associated Borrelia spp. CONCLUSION: The results of this study suggest for the first time that there is a Borrelia sp. in A. varanense tick in the snake P. reticulatus that might be novel.


Subject(s)
Boidae/parasitology , Borrelia/genetics , Ixodidae/microbiology , Lyme Disease/microbiology , Phylogeny , Relapsing Fever/microbiology , Tick Infestations/veterinary , Animals , RNA, Bacterial/genetics , RNA, Ribosomal, 16S/genetics
2.
Exp Physiol ; 99(3): 530-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24273303

ABSTRACT

This report summarizes work investigating the effects of some medicinal plants on uterine contraction. As there is a clinical need to find better drugs to help control uterine activity, and novel compounds are sought, the mechanisms whereby the medicinal plants exert their effects, as well as their major compounds, are discussed. By identifying the plants, major constituents and mechanisms, this review also illustrates the potential for development of new drugs, so that better ways to treat uterine disorders will be available to women worldwide.


Subject(s)
Myometrium/drug effects , Plants, Medicinal , Animals , Female , Humans , Muscle Relaxation/drug effects , Uterine Contraction/drug effects , Uterus/drug effects
3.
Reprod Sci ; 18(6): 516-24, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21566246

ABSTRACT

The aim of this study was to investigate the effects of wild ginger (Costus speciosus (Koen) Smith, Costaceae) rhizome extract on uterine contractility. We particularly examined the effects on spontaneous phasic contractions and the mechanisms whereby it exerts its effects. Wild ginger rhizomes were ethanolic extracted and their constituents analyzed. Isometric force was measured in strips of longitudinal myometrium and the effects of the extract studied. The extract (10 mg/100 mL) increased spontaneous contractions. The amplitude and frequency of the phasic contraction were significantly increased along with basal tension. Force produced in the presence of the extract was abolished by inhibition of l-type calcium channels or myosin light chain kinase (MLCK). The actions of the extract were not blocked by the estrogen receptor blocker, fulvestrant. Although significant amounts of diosgenin were present in the extract, we found that, depending upon its concentration, diosgenin had either no effect or was inhibitory on force. Interestingly, the extract induced significant amounts of force in the absence of extracellular calcium, which could be blocked by inhibition of the sarcoplasmic reticulum calcium-ATPase (SERCA), but not fulvestrant. We conclude that wild ginger rhizome extract stimulates phasic activity in rat uterus. Our data suggest that the uterotonic effect is due to nonestrogenic effects and not those of diosgenin. Wild ginger was able to increase contraction via calcium entry on l-type calcium channels and sarcoplasmic reticulum (SR) calcium release. We suggest that wild ginger rhizome extract may be a useful uterine stimulant.


Subject(s)
Asarum/chemistry , Diosgenin/pharmacology , Myometrium/drug effects , Plant Extracts/pharmacology , Rhizome/chemistry , Uterine Contraction/drug effects , Animals , Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Female , Fulvestrant , Myosin-Light-Chain Kinase/antagonists & inhibitors , Rats , Rats, Wistar , Sarcoplasmic Reticulum Calcium-Transporting ATPases/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...